Tag Archives: matched cohort
GLP-1 in Ulcerative Colitis: 66.7% vs 25.3% at 12 Weeks
GLP-1 receptor agonist users with ulcerative colitis reached remission far more often than matched controls. Weight loss was not associated with it.
No account yet?
Create an AccountJoin the list for batch updates and new compound announcements. We will send you a single-use 8% code once you confirm your address.
Every batch is tested separately
Purity is measured per production lot, not once per product.
See the batch records